Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
13.90
+0.19 (1.39%)
At close: Aug 13, 2025, 4:00 PM
13.96
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:39 AM EDT
Keros Therapeutics Analyst Ratings
Total Analysts
14
Consensus Rating
Buy
Price Target
$20.56
Upside
+47.91%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $20 | Strong Buy | Maintains | $25 → $20 | +43.88% | Aug 8, 2025 |
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $32 → $18 | Strong Buy → Hold | Downgrades | $32 → $18 | +29.50% | Jun 10, 2025 |
| Wedbush | Wedbush | Hold Reiterates $15 | Hold | Reiterates | $15 | +7.91% | May 30, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $41 → $26 | Buy | Maintains | $41 → $26 | +87.05% | May 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $25 | Strong Buy | Maintains | $40 → $25 | +79.86% | May 8, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $43 → $25 | Strong Buy | Maintains | $43 → $25 | +79.86% | Apr 9, 2025 |
| Wedbush | Wedbush | Hold Reiterates $15 | Hold | Reiterates | $15 | +7.91% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +187.77% | Apr 1, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $28 → $26 | Buy | Maintains | $28 → $26 | +87.05% | Feb 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $47 → $40 | Strong Buy | Maintains | $47 → $40 | +187.77% | Feb 27, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 21, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $40 → $15 | Buy | Maintains | $40 → $15 | +7.91% | Jan 17, 2025 |
| Wedbush | Wedbush | Buy → Hold Downgrades $47 → $15 | Buy → Hold | Downgrades | $47 → $15 | +7.91% | Jan 17, 2025 |
| Guggenheim | Guggenheim | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 17, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $44 → $41 | Buy | Maintains | $44 → $41 | +194.96% | Jan 16, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $63 → $23 | Buy | Maintains | $63 → $23 | +65.47% | Jan 16, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.